Ht-Logo-gigapixel-icon
Thursday, November 21, 2024
Canada’s Politics and Government News Source Since 1989
Thursday, November 21, 2024 | Latest Paper

Colleen Fuller

A national pharmacare plan should cover what’s best for patients, not what’s new

Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Opinion | BY COLLEEN FULLER, SHARON BATT | April 1, 2024
Coverage should be based on the best and most independent evidence available or we risk throwing money away on drugs and devices that are neither cost-effective nor providing patients with better health outcomes, write Colleen Fuller and Sharon Batt. Unsplash photograph by Towfiqu Barbhuiya